Jeffrey Howard, associate professor of public health at UTSA, Alicia Swan, director of rehabilitation research at the U.S. Department of Veterans Affairs, and Sara Mithani, assistant professor at the ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentationPRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- ...

In a phase 2b study, treatment with a once-daily oral PCSK9 inhibitor added to statin therapy resulted in a more than 50% ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET. Company Participants. Douglas Onsi - President ...

and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25 - 30 in Chicago. In an oral presentation, Lilly ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

These clinical researchers investigate different aspects of diabetes such as effects of gastric bypass surgery, diet and nutrient interventions and novel pharmacological treatments. Short laymen ...

Placebo controls are a mainstay of clinical research in medicine. They are one of the features imparting gold standard status to the iconic “randomized, double-blind, placebo-controlled clinical trial ...

An expert discusses how the clinical presentations of atopic dermatitis (AD) vary across different patient populations and the challenges these variations pose in diagnosis. Now Viewing EP: 1 .